-
Something wrong with this record ?
Dye labeling for optical imaging biases drug carriers' biodistribution and tumor uptake
S. Schraven, S. Rosenhain, R. Brueck, TM. Wiechmann, R. Pola, T. Etrych, W. Lederle, T. Lammers, F. Gremse, F. Kiessling
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Fluorescent Dyes chemistry MeSH
- Mice MeSH
- Cell Line, Tumor MeSH
- Neoplasms * diagnostic imaging drug therapy MeSH
- Drug Carriers * chemistry MeSH
- Optical Imaging MeSH
- Tissue Distribution MeSH
- Bias MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Biodistribution analyses of nanocarriers are often performed with optical imaging. Though dye tags can interact with transporters, e.g., organic anion transporting polypeptides (OATPs), their influence on biodistribution was hardly studied. Therefore, this study compared tumor cell uptake and biodistribution (in A431 tumor-bearing mice) of four near-infrared fluorescent dyes (AF750, IRDye750, Cy7, DY-750) and dye-labeled poly(N-(2-hydroxypropyl)methacrylamide)-based nanocarriers (dye-pHPMAs). Tumor cell uptake of hydrophobic dyes (Cy7, DY-750) was higher than that of hydrophilic dyes (AF750, IRDye750), and was actively mediated but not related to OATPs. Free dyes' elimination depended on their hydrophobicity, and tumor uptake correlated with blood circulation times. Dye-pHPMAs circulated longer and accumulated stronger in tumors than free dyes. Dye labeling significantly influenced nanocarriers' tumor accumulation and biodistribution. Therefore, low-interference dyes and further exploration of dye tags are required to achieve the most unbiased results possible. In our assessment, AF750 and IRDye750 best qualified for labeling hydrophilic nanocarriers.
Fraunhofer MEVIS Institute for Medical Image Computing Aachen Germany
Gremse IT GmbH Dennewartstrasse 25 52068 Aachen Germany
Helmholtz Institute for Biomedical Engineering RWTH Aachen University Aachen Germany
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23004309
- 003
- CZ-PrNML
- 005
- 20230425141259.0
- 007
- ta
- 008
- 230418s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.nano.2023.102650 $2 doi
- 035 __
- $a (PubMed)36623712
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Schraven, Sarah $u Institute for Experimental Molecular Imaging, RWTH Aachen University, Forckenbeckstrasse 55, 52074 Aachen, Germany
- 245 10
- $a Dye labeling for optical imaging biases drug carriers' biodistribution and tumor uptake / $c S. Schraven, S. Rosenhain, R. Brueck, TM. Wiechmann, R. Pola, T. Etrych, W. Lederle, T. Lammers, F. Gremse, F. Kiessling
- 520 9_
- $a Biodistribution analyses of nanocarriers are often performed with optical imaging. Though dye tags can interact with transporters, e.g., organic anion transporting polypeptides (OATPs), their influence on biodistribution was hardly studied. Therefore, this study compared tumor cell uptake and biodistribution (in A431 tumor-bearing mice) of four near-infrared fluorescent dyes (AF750, IRDye750, Cy7, DY-750) and dye-labeled poly(N-(2-hydroxypropyl)methacrylamide)-based nanocarriers (dye-pHPMAs). Tumor cell uptake of hydrophobic dyes (Cy7, DY-750) was higher than that of hydrophilic dyes (AF750, IRDye750), and was actively mediated but not related to OATPs. Free dyes' elimination depended on their hydrophobicity, and tumor uptake correlated with blood circulation times. Dye-pHPMAs circulated longer and accumulated stronger in tumors than free dyes. Dye labeling significantly influenced nanocarriers' tumor accumulation and biodistribution. Therefore, low-interference dyes and further exploration of dye tags are required to achieve the most unbiased results possible. In our assessment, AF750 and IRDye750 best qualified for labeling hydrophilic nanocarriers.
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a nosiče léků $x chemie $7 D004337
- 650 _2
- $a tkáňová distribuce $7 D014018
- 650 12
- $a nádory $x diagnostické zobrazování $x farmakoterapie $7 D009369
- 650 _2
- $a fluorescenční barviva $x chemie $7 D005456
- 650 _2
- $a optické zobrazování $7 D061848
- 650 _2
- $a zkreslení výsledků (epidemiologie) $7 D015982
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Rosenhain, Stefanie $u Institute for Experimental Molecular Imaging, RWTH Aachen University, Forckenbeckstrasse 55, 52074 Aachen, Germany; Gremse-IT GmbH, Dennewartstrasse 25, 52068 Aachen, Germany
- 700 1_
- $a Brueck, Ramona $u Institute for Experimental Molecular Imaging, RWTH Aachen University, Forckenbeckstrasse 55, 52074 Aachen, Germany
- 700 1_
- $a Wiechmann, Tim Marvin $u Institute for Experimental Molecular Imaging, RWTH Aachen University, Forckenbeckstrasse 55, 52074 Aachen, Germany
- 700 1_
- $a Pola, Robert $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 162 06 Prague, Czech Republic
- 700 1_
- $a Etrych, Tomáš $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 162 06 Prague, Czech Republic
- 700 1_
- $a Lederle, Wiltrud $u Institute for Experimental Molecular Imaging, RWTH Aachen University, Forckenbeckstrasse 55, 52074 Aachen, Germany
- 700 1_
- $a Lammers, Twan $u Institute for Experimental Molecular Imaging, RWTH Aachen University, Forckenbeckstrasse 55, 52074 Aachen, Germany
- 700 1_
- $a Gremse, Felix $u Institute for Experimental Molecular Imaging, RWTH Aachen University, Forckenbeckstrasse 55, 52074 Aachen, Germany; Gremse-IT GmbH, Dennewartstrasse 25, 52068 Aachen, Germany
- 700 1_
- $a Kiessling, Fabian $u Institute for Experimental Molecular Imaging, RWTH Aachen University, Forckenbeckstrasse 55, 52074 Aachen, Germany; Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany; Fraunhofer MEVIS, Institute for Medical Image Computing, Aachen, Germany. Electronic address: fkiessling@ukaachen.de
- 773 0_
- $w MED00167284 $t Nanomedicine : nanotechnology, biology, and medicine $x 1549-9642 $g Roč. 48, č. - (2023), s. 102650
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36623712 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20230425141255 $b ABA008
- 999 __
- $a ok $b bmc $g 1924781 $s 1190518
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 48 $c - $d 102650 $e 20230107 $i 1549-9642 $m Nanomedicine $n Nanomedicine $x MED00167284
- LZP __
- $a Pubmed-20230418
